Citius Pharmaceuticals Inc (CTXR:NASDAQ)

$0.7542 0.00 (0.56%)

watchlist-icon
search-icon
Profile Icon

This Week's Average Sentiment Analysis Score (0 to 100): 82

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]

Change Analysis Timeline Daily Weekly Monthly

Analysed Citius Pharmaceuticals Inc (CTXR:NASDAQ) News Sources

Citius Pharmaceuticals, Inc. Secures $3.8 million through New Jersey Economic Development Program

Yahoo Finance

external link

Cyprium Therapeutics inks agreement to sell rare paediatric disease priority review voucher for $205 million

Pharmabiz

external link
CTXR stock
CTXR stock price
CTXR stock price today
CTXR stock prediction
CTXR earnings date
CTXR news
CTXR price
CTXR share
CTXR share price
CTXR shares
CTXR ceo
CTXR premarket
$CTXR
CTXR ticker
CTXR after hours
CTXR stock
CTXR stock price
CTXR stock price today
CTXR stock prediction
CTXR earnings date
CTXR news
CTXR price
CTXR share
CTXR share price
CTXR shares
CTXR ceo
CTXR premarket
$CTXR
CTXR ticker
CTXR after hours

Citius Pharmaceuticals Inc (CTXR:NASDAQ) FAQs

toggle

What is the current price of Citius Pharmaceuticals Inc (CTXR:NASDAQ)?

The current price of Citius Pharmaceuticals Inc (CTXR:NASDAQ) is $0.7542.


toggle

Citius Pharmaceuticals Inc (CTXR:NASDAQ) absolute price change since previous trading day?

The absolute price change of Citius Pharmaceuticals Inc (CTXR:NASDAQ) since the previous trading day is $0.00.


toggle

Citius Pharmaceuticals Inc (CTXR:NASDAQ) percentage price change since previous trading day?

The percentage price change of Citius Pharmaceuticals Inc (CTXR:NASDAQ) since the previous trading day is 0.56%.


toggle

What is This Week's average sentiment score for Citius Pharmaceuticals Inc (CTXR:NASDAQ)?

This Week's average sentiment score for Citius Pharmaceuticals Inc (CTXR:NASDAQ) is 82 out of 100.


toggle

What is This Week's average sentiment for Citius Pharmaceuticals Inc (CTXR:NASDAQ)?

This Week's sentiment for Citius Pharmaceuticals Inc (CTXR:NASDAQ) is .


Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.